OLANZAPINE DEXCEL 20 MG

Country: Իսրայել

language: անգլերեն

source: Ministry of Health

active_ingredient:

OLANZAPINE 20 MG

MAH:

DEXCEL PHARMA TECHNOLOGIES LTD

ATC_code:

N05AH03

pharmaceutical_form:

TABLETS

administration_route:

PER OS

manufactured_by:

DEXCEL LTD

therapeutic_group:

OLANZAPINE

therapeutic_indication:

Acute and maintenance treatment of schizophrenia. Olanzapine is indicated for the management of the manifestations of psychotic disorders. Olanzapine is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. Prevention of recurrence in Bipolar Disorder: in patients whose manic episodes has responded to olanzapine treatment, olanzapine is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder: the combination of olanzapine with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.

authorization_date:

2012-05-01